Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the
United States; specifically, the Pfizer–BioNTech, Moderna, and Johnson & Johnson …

Over the course of 1 year, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2:
COVID-19) infection increased to over 103 million cases with over 2.2 million deaths …

Coronavirus 2019 (COVID-19) has created a global pandemic that is devastating human
lives, public healthcare systems, and global economies. Multiple effective and safe COVID …

The rapidly evolving COVID-19 pandemic has resulted in an upsurge of scientific
productivity to help address the global health crisis. One area of active research is the …

Pregnant women are more prone to experience severe COVID-19 disease, including
intensive care unit (ICU) admission, use of invasive ventilation, extracorporeal membrane …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is
associated with significant maternal morbidity and mortality, and its risks can be mitigated …

OBJECTIVE Pregnant people are at increased risk of COVID-19–related morbidity and
mortality, and vaccination presents an important strategy for preventing negative outcomes …

Background COVID-19 in pregnant people increases the risk for poor maternal–fetal
outcomes. However, COVID-19 vaccination hesitancy remains due to concerns over the …

Introduction: The coronavirus disease 2019 (COVID-19) vaccine was developed to stimulate
acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Pregnant women are at increased risk for severe morbidity and mortality following infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading some …